SCHEMBL7410681

SCHEMBL7410681

COc1cc2c(C)nc(OS(=O)(=O)c3ccc(C)cc3)c([N+](=O)[O-])c2cc1OC

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KEAP1 Q14145 1/20 0.41
NFE2L2 Q16236 1/20 0.41
GFER P55789 1/20 0.41
ALDH1A1 P00352 8/20 0.40
MAPT P10636 8/20 0.40
LMNA P02545 3/20 0.40
GAA P10253 2/20 0.40
TDP1 Q9NUW8 3/20 0.38
HTT P42858 2/20 0.38
AGTR1 P30556 1/20 0.37
CYP2C9 P11712 2/20 0.37
CYP2C19 P33261 2/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
PKM P14618 3/20 0.37
KDM4E B2RXH2 2/20 0.37
NPSR1 Q6W5P4 2/20 0.37
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7484135 0.77 KEAP1 (0.51) KEAP1NFE2L2GFERALDH1A1MAPT
SCHEMBL7439631 0.74 MAPT (0.40) ALDH1A1MAPTLMNAGAATDP1
SCHEMBL7409180 0.72 MAPT (0.43) ALDH1A1MAPTLMNAGAATDP1
SCHEMBL17585445 0.72 MAPT (0.46) KEAP1NFE2L2ALDH1A1MAPTLMNA
SCHEMBL7412702 0.72 KDM4E (0.44) GFERALDH1A1MAPTLMNAGAA
SCHEMBL7437559 0.71 KMT2A (0.41) ALDH1A1MAPTLMNATDP1HTT
SCHEMBL4322696 0.70 KEAP1 (0.53) KEAP1NFE2L2ALDH1A1MAPTLMNA
SCHEMBL1494398 0.69 MAPT (0.46) GFERALDH1A1MAPTLMNAGAA
SCHEMBL7411233 0.69 ABCG2 (0.48) ALDH1A1MAPTTDP1HTTCYP2C9
SCHEMBL7441183 0.69 LMNA (0.39) ALDH1A1MAPTLMNATDP1PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4843077-A Isoquinoline derivatives having renal vasodilating properties and/or cardiotonic properties and/or phosphodiesterase inhibiting properties ORTHO PHARMACEUTICAL CORPORATION (US) 1989-06-27 US disclosed